Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 601, pseudogene (RN7SL601P)

Target
RN7SL601P
Molecular classification
Other (non-coding RNA pseudogene; does not fit into categories like receptor, enzyme, transporter, etc.)
01

Overview

RN7SL601P is a human genomic locus annotated as a pseudogene derived from the 7SL RNA, which is normally an essential component of the signal recognition particle (SRP), mediating the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum[4][12][11]. However, as a pseudogene, RN7SL601P does not encode a functional 7SL RNA and is viewed as a truncated, non-expressed remnant originating from reverse transcription or duplication of authentic 7SL RNA genes[10]. Pseudogenes like RN7SL601P show structural variation and are dispersed within the human genome, but their role is primarily non-functional, with no validated connection to cellular signaling, protein synthesis, disease, or therapeutic intervention[10][11]. There is no evidence that RN7SL601P participates in canonical RNA-mediated regulatory functions, interacts with drugs, or acts as a biomarker or disease modifier. Thus, it should not be considered a biological target in therapeutic or diagnostic contexts.

Other names
RN7SL601PRNA, 7SL, cytoplasmic 601, pseudogene
02

Mechanism of action

None (as there are no known drugs or mechanisms targeting this pseudogene)

03

Biological functions

None (pseudogenes generally do not produce functional RNA or protein; while some pseudogenes may have regulatory functions, no evidence supports such a role for RN7SL601P specifically)
04

Disease associations

None (no established direct disease roles for RN7SL601P; RN7SL pseudogenes in general are not individually linked to disease)
05

Safety considerations

None (no direct safety concerns or therapeutic challenges are associated with this pseudogene)
06

Interacting drugs

None (no drugs interact with this pseudogene)
07

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 601, pseudogene (RN7SL601P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 601, pseudogene (RN7SL601P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call